BWS
AZN icon

Buck Wealth Strategies’s AstraZeneca AZN Stock Holding History

Buck Wealth Strategies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6K Buy
+19
New +$3.57K ﹤0.01% 778

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Buck Wealth Strategies's AZN Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in AstraZeneca (AZN) in Q2 2026: 19 shares worth $3.6K. The stake represents ﹤0.01% of the portfolio and ranks #778 among its holdings.

977 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Buck Wealth Strategies held 19 shares of AstraZeneca worth $3.6K as of Q2 2026.
  • AstraZeneca was a new Buck Wealth Strategies position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #778 holding.
  • 977 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.